AroCell AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.10.18	AroCell AB announces the appointment of a new CEO (GlobeNewswire)
17.10.18	Patent granted in the US (GlobeNewswire)
09.10.18	A second abstract accepted at ISOBM in Hamburg demonstrating enhanced diagnostic value when using AroCell’s proprietary sample preparation method (GlobeNewswire)
18.09.18	A new study comparing TK 210™ ELISA from AroCell with other activity-based assays for the measurement of TK1 in serum shows high correlation between methods when samples from subjects with hematologic (GlobeNewswire)
29.08.18	Patent reinforces AroCell’s opportunities in the US market (GlobeNewswire)
24.08.18	New Publication from AroCell AB Demonstrating the Value of Thymidine Kinase 1 as a Tumor Biomarker (GlobeNewswire)
18.01.18	AroCell AB: AroCell på den asiatiska marknaden (GlobeNewswire)
22.11.17	AroCell AB (publ) signs Letter of Intent with Korean-based company, Green Cross Cell Corporation. (GlobeNewswire)
22.11.17	AroCell AB: Reporting period 1 July - 30 September 2017 (GlobeNewswire)
08.11.17	AroCell AB: Abstract published presenting AroCell TK 210 ELISA from the PROMIX study at the European Society for Medical Oncology Congress in Singapore, November 17-19, 2017 (GlobeNewswire)
13.10.17	AroCell AB: announces that a distribution agreement has been signed with Pathway Diagnostics Ltd, for distribution of the AroCell TK 210 ELISA test in United Kingdom and Ireland. (GlobeNewswire)
26.09.17	AroCell AB: AroCell Research Poster on TK1 / TK 210 ELISA in Prostate Cancer has been accepted for presentation at the UK National Cancer Research Institute (NCRI) Annual Meeting November 2017 (GlobeNewswire)
22.09.17	AroCell AB: TK 210 ELISA abstract on in-vitro studies of cancer drugs has been accepted for presentation at the National Cancer Research Institute (NCRI) UK symposium (GlobeNewswire)
18.09.17	AroCell AB: New application for AroCell TK 210 ELISA opens new opportunities for drug development research (GlobeNewswire)
24.08.17	AroCell AB: Interim report, Q2 2017 (GlobeNewswire)
17.11.16	AroCell: Interim report January - September 2016 (GlobeNewswire)
03.11.16	AroCell: Ann Hammarstrand appointed as new CFO to AroCell (GlobeNewswire)
06.10.16	AroCell AB: AroCell signs distribution agreement with Eagle Biosciences in the United States (GlobeNewswire)
25.08.16	AroCell AB: Interim report January - June 2016 (GlobeNewswire)
12.08.16	AroCell: Improved measurement of Thymidine Kinase 1 within the normal range due to improved composition of the zero calibrator. (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu AroCell AB

Aktien Top/Flop

Meistgelesene Nachrichten